Cargando…
Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
SARS-CoV-2 ‘Variants of Concern’ (VOCs) continue to reshape the trajectory of the COVID-19 pandemic. However, why some VOCs, like Omicron, become globally dominant while the spread of others is limited is not fully understood. To address this question, we investigated the VOC Mu, which was first ide...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978943/ https://www.ncbi.nlm.nih.gov/pubmed/35378749 http://dx.doi.org/10.1101/2022.03.28.22273077 |
_version_ | 1784681065312419840 |
---|---|
author | Petrone, Mary E. Lucas, Carolina Menasche, Bridget Breban, Mallery I. Yildirim, Inci Campbell, Melissa Omer, Saad B. Ko, Albert I. Grubaugh, Nathan D. Iwasak, Akiko Wilen, Craig B. Vogels, Chantal B.F. Fauver, Joseph R. |
author_facet | Petrone, Mary E. Lucas, Carolina Menasche, Bridget Breban, Mallery I. Yildirim, Inci Campbell, Melissa Omer, Saad B. Ko, Albert I. Grubaugh, Nathan D. Iwasak, Akiko Wilen, Craig B. Vogels, Chantal B.F. Fauver, Joseph R. |
author_sort | Petrone, Mary E. |
collection | PubMed |
description | SARS-CoV-2 ‘Variants of Concern’ (VOCs) continue to reshape the trajectory of the COVID-19 pandemic. However, why some VOCs, like Omicron, become globally dominant while the spread of others is limited is not fully understood. To address this question, we investigated the VOC Mu, which was first identified in Colombia in late 2020. Our study demonstrates that, although Mu is less sensitive to neutralization compared to variants that preceded it, it did not spread significantly outside of South and Central America. Additionally, we find evidence that the response to Mu was impeded by reporting delays and gaps in the global genomic surveillance system. Our findings suggest that immune evasion alone was not sufficient to outcompete highly transmissible variants that were circulating concurrently with Mu. Insights into the complex relationship between genomic and epidemiological characteristics of previous variants should inform our response to variants that are likely to emerge in the future. |
format | Online Article Text |
id | pubmed-8978943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-89789432022-04-05 Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu Petrone, Mary E. Lucas, Carolina Menasche, Bridget Breban, Mallery I. Yildirim, Inci Campbell, Melissa Omer, Saad B. Ko, Albert I. Grubaugh, Nathan D. Iwasak, Akiko Wilen, Craig B. Vogels, Chantal B.F. Fauver, Joseph R. medRxiv Article SARS-CoV-2 ‘Variants of Concern’ (VOCs) continue to reshape the trajectory of the COVID-19 pandemic. However, why some VOCs, like Omicron, become globally dominant while the spread of others is limited is not fully understood. To address this question, we investigated the VOC Mu, which was first identified in Colombia in late 2020. Our study demonstrates that, although Mu is less sensitive to neutralization compared to variants that preceded it, it did not spread significantly outside of South and Central America. Additionally, we find evidence that the response to Mu was impeded by reporting delays and gaps in the global genomic surveillance system. Our findings suggest that immune evasion alone was not sufficient to outcompete highly transmissible variants that were circulating concurrently with Mu. Insights into the complex relationship between genomic and epidemiological characteristics of previous variants should inform our response to variants that are likely to emerge in the future. Cold Spring Harbor Laboratory 2022-03-30 /pmc/articles/PMC8978943/ /pubmed/35378749 http://dx.doi.org/10.1101/2022.03.28.22273077 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Petrone, Mary E. Lucas, Carolina Menasche, Bridget Breban, Mallery I. Yildirim, Inci Campbell, Melissa Omer, Saad B. Ko, Albert I. Grubaugh, Nathan D. Iwasak, Akiko Wilen, Craig B. Vogels, Chantal B.F. Fauver, Joseph R. Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu |
title | Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu |
title_full | Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu |
title_fullStr | Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu |
title_full_unstemmed | Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu |
title_short | Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu |
title_sort | insights into the limited global spread of the immune evasive sars-cov-2 variant mu |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978943/ https://www.ncbi.nlm.nih.gov/pubmed/35378749 http://dx.doi.org/10.1101/2022.03.28.22273077 |
work_keys_str_mv | AT petronemarye insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT lucascarolina insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT menaschebridget insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT brebanmalleryi insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT yildiriminci insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT campbellmelissa insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT omersaadb insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT koalberti insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT grubaughnathand insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT iwasakakiko insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT wilencraigb insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT vogelschantalbf insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu AT fauverjosephr insightsintothelimitedglobalspreadoftheimmuneevasivesarscov2variantmu |